AbbVie's Kirsten O'Doherty, Pfizer's Melissa McGregor and Kathy Connell of Johnson & Johnson Innovation, discuss why companies focus on diversity, why some may not, and how PAGE has uncovered different attitudes and experiences across the sector.
PAGE co-founders on 'opening the door' to discussions on diversity
August 21, 2019 Latest NewsBioPharmaDispatch ExecutiveNews of the DayPodcast
Latest Video
New Stories
-
Government moves on general co-pay as safety gets further out of reach
July 29, 2025 - - Latest News -
'For these families, genomics is not a luxury—it’s the only viable path'
July 29, 2025 - - Latest News -
Pharmac identifies the wider societal benefit of treatments for chronic conditions
July 28, 2025 - - Latest News -
Australian cell therapy company appoints experienced executive as CEO
July 28, 2025 - - Australian Biotech -
Alterity Therapeutics reports positive topline data from Phase 2 trial of ATH434
July 28, 2025 - - Australian Biotech -
Radiopharm Theranostics receives IND approval to initiate Phase 1 study
July 28, 2025 - - Australian Biotech -
Clarity successfully completes $203 million institutional placement
July 28, 2025 - - Australian Biotech